C M Bidwell & Associates LTD Catalent, Inc. Transaction History

C M Bidwell & Associates LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	BUY	$45.44 - $74.26 $1,635 - $2,673	36 New	36 $2,000
Q2 2022 Aug 12, 2022	SELL	$87.2 - $114.05 $7,848 - $10,264	-90 Reduced 3.82%	2,265 $243,000
Q4 2021 Feb 11, 2022	BUY	$119.57 - $139.07 $15,185 - $17,661	127 Added 5.7%	2,355 $302,000
Q3 2021 Nov 12, 2021	SELL	$109.17 - $142.35 $4,039 - $5,266	-37 Reduced 1.63%	2,228 $296,000
Q2 2021 Aug 13, 2021	BUY	$100.34 - $115.69 $18,061 - $20,824	180 Added 8.63%	2,265 $245,000
Q1 2021 May 14, 2021	BUY	$101.51 - $125.27 $86,080 - $106,228	848 Added 68.55%	2,085 $220,000
Q4 2020 Feb 16, 2021	SELL	$85.88 - $105.36 $1,545 - $1,896	-18 Reduced 1.43%	1,237 $129,000
Q3 2020 Nov 13, 2020	BUY	$72.74 - $92.5 $91,288 - $116,087	1,255 New	1,255 $108,000

513

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of C M Bidwell & Associates LTD, based on Form 13F filings with the SEC.

Stay updated on C M Bidwell & Associates LTD with notifications on news.